Pharmaceutical Warehousing Market By Type (Cold Chain Warehousing, Non-Cold Chain Warehousing), By Applications (Pharmaceutical Factory, Pharmacy, Hospital, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

Pharmaceutical warehousing is the storage and management of pharmaceutical products in a controlled environment such as cold chain and non-cold chain warehouses. These warehousing facilities are vital parts of the overall pharmaceutical supply chain, enabling safe, secure, and compliant storage of an extensive range of pharmaceutical items, including raw materials, and finished products.

Pharmaceutical Warehousing Market - IMG1

Pharmaceutical warehousing is an essential element of the overall pharmaceutical logistics chain. Pharmaceutical warehousing provides optimal storage for temperature, light, and humidity sensitive medications, as a result, pharmaceutical medications are stored and delivered to patients in an organized way.

The expansion of global pharmaceutical warehousing market is driven by growth in the pharmaceutical, increase in demand from the e-commerce industry, and increase in demand for reverse logistics. However, lack of standardization in pharmaceutical logistics & storage and poor infrastructure & higher logistics costs hinder market growth. Furthermore, factors such as introduction of the blockchain technology and technological growth in pharmaceutical warehousing market are expected to provide lucrative growth opportunity during the forecast period.

Medicine manufacturers are increasingly concerned with the quality and sensitivity of medicinal goods. Factors such as the creation of sophisticated biological-based medications and the distribution of hormone therapies, vaccinations, and complex proteins need the use of specialized transportation and storage. Temperature-controlled logistics and storage for pharmaceutical items and medical equipment is a rapidly expanding segment of the pharmaceutical warehousing business. Furthermore, the increased demand for effective cold chain logistics services to ensure product quality drives the growth of the pharmaceutical warehousing industry.

During the COVID-19 pandemic, the number of pharmaceutical demands from online channels expanded dramatically. Moreover, the demand for time-efficient delivery and reverse logistics has increased. The surge in sales of pharmaceutical logistics through online channels increased the need for storage, generating a demand for the pharmaceutical warehousing industry. The COVID-19 pandemic had a favorable effect on the pharmaceutical warehousing industry. As the pandemic resulted in governments throughout the world adopting strict measures to combat the virus. Governments and regulatory agencies throughout the world began stockpiling crucial medications and pharmaceutical treatments to halt the virus spread. At the same time, the demand for cold chain warehousing increased as it was utilized to store temperature-sensitive pharmaceuticals, fueling total market demand.

Moreover, due to rise in concerns regarding energy conservation and environment protection, pharmaceutical warehouse service providers are increasingly investing in cost-effective warehousing solutions that combine green practices and smart technology, such as the Internet of Things (IoT), smart sensors, and robotics. In addition, vendors provide digital tools to automate pharmaceutical warehousing and process data with enhanced productivity, efficiency, and convenience. Moreover, growth in use of Artificial Intelligence (AI), machine learning, radio-frequency identification (RFID), and Bluetooth further helps in improving pharmaceutical warehouse operations. Therefore, technological advancements in the logistics industry offer lucrative growth opportunities for the pharmaceutical logistics market.

However, an effective pharmaceutical logistics ecosystem necessitates sophisticated infrastructure, a well-organized supply chain, and trade facilitation measures. Without these, pharmaceutical warehousing companies must engage in expanding their stock reserves and working capital, which have a significant impact on national and regional competitiveness owing to high financial expenses. Furthermore, factors such as inefficiencies in transport management systems, poor storage infrastructure condition, complex tax structure, low rate of technology adoption, and low proficiency of warehouse professionals in using digitalization tools slow the pace and productivity of pharmaceutical warehousing market.

The pharmaceutical warehousing market is segmented into type, application, and region. Depending on type, the global pharmaceutical market share is classified into cold chain warehousing and non-cold chain warehousing. On the basis of application, it is divided into pharmaceutical factories, pharmacies, hospitals, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in the report include RSA TALKE, KEMITO, Brenntag SE, Rinchem Company, LLC, Univar Solutions LLC, Commonwealth Inc., DHL GROUP, Anchor 3PL, Broekman Logistics and Odyssey Logistics & Technology Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical warehousing market analysis from 2022 to 2032 to identify the prevailing pharmaceutical warehousing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pharmaceutical warehousing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pharmaceutical warehousing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Investment Opportunities
New Product Development/ Product Matrix of Key Players
SWOT Analysis

Key Market Segments

By Type

Cold Chain Warehousing
Non-Cold Chain Warehousing

By Applications

Pharmacy
Hospital
Others
Pharmaceutical Factory

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- South Africa

Key Market Players:

RSA TALKE
KEMITO
Brenntag SE
Rinchem Company, LLC
Univar Solutions LLC
Commonwealth Inc.
DHL GROUP
Anchor 3PL
Broekman Logistics
Odyssey Logistics & Technology Corporation

Product Code: A124142

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: PHARMACEUTICAL WAREHOUSING MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Cold Chain Warehousing
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Non-Cold Chain Warehousing
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL WAREHOUSING MARKET, BY APPLICATIONS

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Pharmaceutical Factory
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Pharmacy
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Hospital
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: PHARMACEUTICAL WAREHOUSING MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Type
- 6.2.3. Market size and forecast, by Applications
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Market size and forecast, by Type
  - 6.2.4.1.2. Market size and forecast, by Applications
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Market size and forecast, by Type
  - 6.2.4.2.2. Market size and forecast, by Applications
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Market size and forecast, by Type
  - 6.2.4.3.2. Market size and forecast, by Applications
6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Type
- 6.3.3. Market size and forecast, by Applications
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Market size and forecast, by Type
  - 6.3.4.1.2. Market size and forecast, by Applications
  - 6.3.4.2. UK
  - 6.3.4.2.1. Market size and forecast, by Type
  - 6.3.4.2.2. Market size and forecast, by Applications
  - 6.3.4.3. France
  - 6.3.4.3.1. Market size and forecast, by Type
  - 6.3.4.3.2. Market size and forecast, by Applications
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Market size and forecast, by Type
  - 6.3.4.4.2. Market size and forecast, by Applications
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Market size and forecast, by Type
  - 6.3.4.5.2. Market size and forecast, by Applications
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Market size and forecast, by Type
  - 6.3.4.6.2. Market size and forecast, by Applications
6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Type
- 6.4.3. Market size and forecast, by Applications
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Market size and forecast, by Type
  - 6.4.4.1.2. Market size and forecast, by Applications
  - 6.4.4.2. India
  - 6.4.4.2.1. Market size and forecast, by Type
  - 6.4.4.2.2. Market size and forecast, by Applications
  - 6.4.4.3. Japan
  - 6.4.4.3.1. Market size and forecast, by Type
  - 6.4.4.3.2. Market size and forecast, by Applications
  - 6.4.4.4. South Korea
  - 6.4.4.4.1. Market size and forecast, by Type
  - 6.4.4.4.2. Market size and forecast, by Applications
  - 6.4.4.5. Australia
  - 6.4.4.5.1. Market size and forecast, by Type
  - 6.4.4.5.2. Market size and forecast, by Applications
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Market size and forecast, by Type
  - 6.4.4.6.2. Market size and forecast, by Applications
6.5. LAMEA
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Type
- 6.5.3. Market size and forecast, by Applications
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Latin America
  - 6.5.4.1.1. Market size and forecast, by Type
  - 6.5.4.1.2. Market size and forecast, by Applications
  - 6.5.4.2. Middle East
  - 6.5.4.2.1. Market size and forecast, by Type
  - 6.5.4.2.2. Market size and forecast, by Applications
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Market size and forecast, by Type
  - 6.5.4.3.2. Market size and forecast, by Applications

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. Odyssey Logistics & Technology Corporation
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
8.2. Univar Solutions LLC
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Rinchem Company, LLC
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
8.4. Anchor 3PL
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
8.5. Brenntag SE
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
8.6. Broekman Logistics
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
8.7. Commonwealth Inc.
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
8.8. DHL GROUP
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
8.9. RSA TALKE
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
8.10. KEMITO
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments